Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 22, 2023
The IMF has now approved ten new loans to countries under its new Resilience and Sustainability Trust (RST), established in 2022 to provide financial support on concessional terms to countries facing long-term structural challenges arising from two key threats: climate change and pandemic preparedne...
Blog Post
September 19, 2023
Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. The African Union’s admission to the G20 provides an opportunity for ...
Blog Post
September 13, 2023
Olu Verheijen from the Nigerian government and Vijaya Ramachandran from the Breakthrough Institute join Gyude to discuss the scale and nature of the energy crisis in Africa, the role that renewable energy can (and can't) play in addressing it, and what steps African countries—and partners—can take t...
Blog Post
September 12, 2023
I utterly didn’t foresee the revolution in mobile internet services, and the incredibly innovative ways that it would be used. Back in 2002, 11 percent of the world’s population were internet users. Today, it is 63 percent—the considerable majority using connections over cheap mobile phones. Even in...
Blog Post
September 07, 2023
We have reviewed each of the UK’s seven main finance tools—from export finance to capital increases at its private finance arm, British International Investment. Overall, we find that the UK has substantially increased the level of finance it mobilises, from around £3bn in 2018, to £5bn in 2021, and...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
September 05, 2023
We know from data across countries that far too many children around the world experience violence at school. For example, evidence from 20 African countries shows high rates of both physical and sexual violence. But qualitative studies with smaller samples or more targeted quantitative studies can ...